To establish and evaluate a community-oriented comprehensive HAE diagnosis and management program at a regional center in central China; characterize the clinical and biochemical phenotypes of three unrelated families; identify SERPING1 variants; implement personalized treatment and family cascade screening; and evaluate key program elements as a proof-of-concept model. This evidence concerns the gene SERPING1 and hereditary angioedema.